Neon Therapeutics, Inc. (NTGN) relating to its sale to BioNTech SE. Under the terms of the sale, each share of Neon common stock will be automatically converted into the right to receive 0.063 of an American Depositary Share of BioNTech SE.
Neon Therapeutics, Inc. (NTGN) relating to its sale to BioNTech SE. Under the terms of the sale, each share of Neon common stock will be automatically converted into the right to receive 0.063 of an American Depositary Share of BioNTech SE.